Month: March 2026

Companies advance plans for global system architecture and shared infrastructure for Direct-to-Device and other Advanced Mobile Satellite Services BARCELONA, Spain, March 02, 2026 (GLOBE NEWSWIRE) — Space42, the UAE-based AI-powered SpaceTech company, and Viasat, Inc., a global leader in satellite communications, will discuss continued progress toward their planned direct-to-device (D2D) infrastructure and offer an early look at the priorities for Equatys, the companies’ forthcoming joint entity, during a co-hosted program at Mobile World Congress in Barcelona this week. The program marks the first public showcase of Equatys’ technical direction and commercial vision, reflecting its ambition to accelerate global D2D adoption.   This event brings together policymakers, regulators, and industry leaders to explore how...

Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related diseaseDesignation based on positive data from a phase 2 study of rilzabrutinib in IgG4-RD Third global orphan drug designation for rilzabrutinib in IgG4-RD, underpinning Sanofi’s commitment to rare immune-mediated diseasesParis, March 2, 2026 – The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted orphan drug designation to rilzabrutinib, a novel, oral, reversible covalent Bruton’s tyrosine kinase (BTK) inhibitor, for IgG4-related disease (IgG4-RD). There is still unmet medical need and limited treatment options in Japan for IgG4-RD, a rare, progressive, immune-mediated chronic condition in which the immune system attacks various tissues and organs leading to serious damage. The MHLW grants orphan designation to medicines that address...

Press releaseRegulated information Brussels, March 2, 2026, 7.00 am CET Solvac is closely monitoring the situation and is in close contact with Syensqo’s Board of Directors and management. Solvac is fully mobilised in its role as a long‑term reference shareholder and is acting alongside Syensqo to support the company through this phase. Solvac is a public limited company under Belgian law founded in 1983 and listed on the Euronext Brussels stock exchange under the ISIN code BE0003545531 (SOLV). Its assets consist exclusively of a stake of more than 30% in the capital of Solvay SA and in the capital of Syensqo SA. Its titles are exclusively nominative. They may be held freely by individuals or, with the approval of the Board of Directors, by legal entities or similar entities under the conditions set out in their approval policy. As of...

PHOTONIS DEFENSE AWARDED U.S. ARMY BINOD CONTRACT FOR ADVANCED NIGHT VISION SOLUTIONS, A STRATEGIC MILESTONE FOR EXOSENS’ EXPANSION IN THE U.S.Firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract awarded by the U.S. Army Contracting Command to Photonis Defense, Exosens’ U.S. subsidiary, with a maximum value of US$352.6 million Contract covers the development, production, and testing of the U.S. Army’s Binocular Night Observation Device (BiNOD) program through February 27, 2033 Award marks a key milestone in Exosens’ expansion in the U.S., the world’s most demanding single market for night vision devices, supported by the Group’s scalable industrial footprint in the countryPress release, Mérignac (France), March 2, 2026 – Exosens (EXENS; FR001400Q9V2), a high-tech company focused on providing mission- and performance-critical...

BEIJING, March 01, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that its next generation TRK inhibitor zurletrectinib (ICP-723) has been granted priority review by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA), for the treatment of pediatric patients (aged 2 to 12) with solid tumors harboring NTRK gene fusions. Priority review is one of the key policies introduced by the CDE to accelerate drug approval. Zurletrectinib has also been included in the “SPARK Program” by the CDE, a pilot initiative to encourage the development of pediatric anti-tumor drugs. In December 2025, zurletrectinib received approval for the treatment of adult and adolescent patients (aged 12 years...

SHENZHEN, China, March 02, 2026 (GLOBE NEWSWIRE) — Pony AI Inc. (“Pony.ai” or the “Company”) (NASDAQ: PONY; HKEX: 2026), a global leader in achieving large-scale mass production and commercialization of autonomous driving technology, today announced that it has achieved seventh-generation (“Gen-7”) Robotaxi unit economics (“UE”) breakeven1 in Shenzhen. This milestone underscores Pony.ai’s capability to realize a sustainable business model, laying a solid foundation to accelerate scale-up over a multi-year horizon. Driven by surging user demand and optimized operational efficiency, Pony.ai’s commercial operations in Shenzhen have delivered outstanding results. As of February 28, the one-month daily average net revenue per Gen-7 Robotaxi has reached RMB338, with a daily average of 23 orders per vehicle. These figures demonstrate...

At Mobile World Congress 2026 in Barcelona, March 2-4, Veea will demonstrate a first-of-a-kind Plug-and-Play 5G FWA with AI-Enhanced Cybersecurity and Value-added Services BARCELONA, Spain, March 01, 2026 (GLOBE NEWSWIRE) — Veea Inc. (“Veea”), a leading-edge supplier of managed networking and secure multiaccess edge computing platform products and solutions, today announced the planned launch of Veea SecureConnect™ service by Telcel in Mexico this week. Veea SecureConnect, being demonstrated at Mobile World Congress, is expected to be offered over a 5G network with one of the broadest coverages in Mexico. Veea SecureConnect is targeted to businesses and enterprises such as pharmacies, branch offices, clinics, medical and dental offices, retailers, QSRs, restaurants, gyms, warehouses, travel agencies, SOHO users, professional...

NEW YORK, March 01, 2026 (GLOBE NEWSWIRE) — In a release issued Wednesday, February 25, 2026 by WeShop Holdings Limited (NASDAQ: WSHP), please note direct references to retailer names should not appear. The corrected release follows: WeShop Holdings Limited (“WeShop” or the “Company”) (NASDAQ: WSHP), the world’s first community-owned social commerce platform, allows shoppers to earn equity while they shop at leading pet retailers giving the over 94 million pet owners in the U.S. even more ways to save while caring for their animals. Within the WeShop app, members can shop a curated selection of pet essentials, including premium pet food, treats, toys, grooming products, health and wellness items, and everyday supplies. By featuring trusted category leaders in its marketplace, WeShop connects routine pet care spending to its ownership-driven...